SUBCELLULAR LOCALIZATION OF HUMAN PLACENTAL ARYL HYDROCARBON HYDROXYLASE

被引：21
作者：
JUCHAU, MR
SMUCKLER, EA
机构：
[1] UNIV WASHINGTON, SCH MED, DEPT PHARMACOL, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON SCH MED, DEPT PATHOL, SEATTLE, WA 98195 USA
来源：
TOXICOLOGY AND APPLIED PHARMACOLOGY | 1973年 / 26卷 / 02期
关键词：
D O I：
10.1016/0041-008X(73)90250-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：163 / 179
页数：17
相关论文
共 50 条
[21]   MATERNAL CIGARETTE-SMOKING, PLACENTAL ARYL-HYDROCARBON HYDROXYLASE AND NEONATAL SIZE [J].
PELKONEN, O ;
KARKI, NT ;
KOIVISTO, M ;
TUIMALA, R ;
KAUPPILA, A .
TOXICOLOGY LETTERS, 1979, 3 (06) :331-335
[22]   HERITABILITY OF ARYL-HYDROCARBON HYDROXYLASE IN CULTURED HUMAN LYMPHOCYTES [J].
PAIGEN, B .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1976, 357 (08) :1047-1048
[23]   ARYL-HYDROCARBON HYDROXYLASE INDUCTION IN CULTURED HUMAN LYMPHOCYTES [J].
ALFRED, L ;
TORRALBA, G .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR) :151-151
[24]   GENETIC-VARIATION OF ARYL HYDROCARBON HYDROXYLASE IN HUMAN LYMPHOCYTES [J].
KELLERMA.G ;
LUYTENKE.M ;
SHAW, CR .
AMERICAN JOURNAL OF HUMAN GENETICS, 1973, 25 (03) :327-331
[25]   ARYL-HYDROCARBON HYDROXYLASE AND 16ALPHA-HYDROXYLASE IN CULTURED HUMAN LYMPHOCYTES [J].
COOMES, ML ;
MASON, WA ;
MUIJSSON, IE ;
CANTRELL, ET ;
ANDERSON, DE ;
BUSBEE, DL .
BIOCHEMICAL GENETICS, 1976, 14 (7-8) :671-685
[26]   ARYL-HYDROCARBON HYDROXYLASE IN PSORIASIS [J].
LYELL, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 8 (02) :260-260
[27]   ARYL-HYDROCARBON HYDROXYLASE AND SMOKING [J].
KELLERMANN, G ;
SHAW, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (07) :411-411
[28]   ARYL-HYDROCARBON HYDROXYLASE IN PSORIASIS [J].
RAWLINS, M ;
SHUSTER, S .
LANCET, 1982, 2 (8292) :271-271
[29]   ARYL-HYDROCARBON HYDROXYLASE AND PSORIASIS [J].
RAWLINS, M ;
SHUSTER, S .
BRITISH MEDICAL JOURNAL, 1982, 285 (6338) :378-378
[30]   ACTIVITY OF ARYL-HYDROCARBON HYDROXYLASE IN ADULT HUMAN-SKIN [J].
CHAPMAN, PH ;
RAWLINS, MD ;
SHUSTER, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (05) :499-503
12345